POTSDAM -- A business now running out of Clarkson’s Shipley Center could bring more than 100 jobs manufacturing jobs to St. Lawrence County.

Shawn Clark and his team at Clark Scientific say they have solved a problem that has challenged researchers for many years.

He and his staff of five researchers set out with the vision of developing a rapid and efficient process for biochemically profiling a protein.

They are now creating the first-ever database of the biochemical parameters for all known proteins, “The Proteome."

“It's very much an honor to be here in this capacity,” says Clark, who graduated from the pre-med biology program at Clarkson University in 1998. He has five degrees, including two doctorates.

Clark Scientific has offices and laboratory space in Clarkson University's business incubator, Peyton Hall.

Beyond the job opportunities presented at Clark Scientific, the board of Clark has committed to moving their manufacturing plant for Delta Tm Technologies, a second corporation, to Potsdam. Because of the funding opportunities and support, Clark says, “We have brought our production facility, of an alternate corporation, from Boston to this area. It could mean 100+ jobs in total with competitive salaries that would not necessarily require an advanced degree.”

“We're in the final stages of securing our technology and partnering with key industrial and academic leaders,” he notes.

Researchers at Clark Scientific are using the database for asking higher-level questions. For instance, what biochemical parameters identify druggability, the reclassification of proteins or the nomination of a new time release formulation.

Clark Scientific will open access to the lower levels of data that contain thousands of biochemical data points in May of 2016. This information will allowresearchers to rapidly identify optimal experimental conditions; managers to confidently nominate programs; and a comparison of current market products prior to purchase, the company said.

“Big Data” is the future for many industries but even more relevant to the scientific community, Clark says, as is evidenced by the tremendous insights gained from the “Human Genome Project.”

“At the root of our expansive data base is a biochemical profile of each protein, including optimal buffer conditions, cryo-storage parameters and crystallization data," says Clark. "The database also contains a small molecule fragment screening library of 700 individually nominated compounds. These data can significantly reduce the cost and time of protein manufacturing and early stage R&D. The information is already compiled, so companies won't have to go through the arduous process of reinventing the wheel. "

“Our database is the only one of its kind,” Clark says. “The scope of this undertaking is so large that, until now, no clear technology could have been identified.”